Middle East Anti-Depressants Drugs Market Analysis

Middle East Anti-Depressants Drugs Market Analysis


$ 3999

The Middle East Anti-Depressants drugs market size was valued at $3.12 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030 and will reach $4.64 Bn in 2030. The market is segmented by drug class, indication, route of administration, end-user, and distribution channel. The Middle East Anti-Depressants drug market will grow because Depression is a common mental health disorder in the Middle East, affecting a significant portion of the population. The key market players are GlaxoSmithKline plc (GBR), AstraZeneca (GBR), Mallinckrodt (GBR), Novartis AG, and others.

ID: IN10MEPH051 CATEGORY: Pharmaceuticals GEOGRAPHY: Middle East AUTHOR: Chandani Patel

Buy Now

Middle East Anti-Depressants Drugs Market Executive Summary

The Middle East Anti-Depressants drugs market size was valued at $3.12 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030 and will reach $4.64 Bn in 2030. One out of every 7 people living in Middle - East countries is suffering from diabetes. Nevertheless, the prevalence of diabetes varied from about 3% in Israel to more than 21.9% in Kuwait. Importantly, it has increased considerably during the last two decades from about 9% to nearly 19% in the region. According to the International Diabetes Federation (IDF), the Middle East and North Africa region (MENA) has the highest prevalence of diabetes among adults aged 20-79 years globally, with an estimated 51 million people living with the condition in 2021. The IDF also estimates that the prevalence of diabetes in the region will increase by 69% between 2021 and 2045.

Within the Middle East, the countries with the highest prevalence of diabetes include Kuwait, Qatar, Saudi Arabia, and the United Arab Emirates. In these countries, the prevalence of diabetes ranges from 16% to 20% among adults aged 20-79 years. Factors contributing to the high prevalence of diabetes in the Middle East include rapid urbanization, changes in lifestyle, and increased rates of obesity and physical inactivity. There is also a high prevalence of risk factors such as tobacco use and unhealthy diets, as well as genetic and environmental factors that may increase the risk of developing diabetes. The high prevalence of diabetes in the Middle East could have an impact on the anti-depressant drugs market, although the nature and extent of this impact would depend on various factors. One potential impact could be an increased demand for anti-depressant drugs among people with diabetes who also experience depression or other mental health issues. Studies have found that people with diabetes are at higher risk of depression than the general population, with rates estimated to be as high as 30%.

This increased demand could lead to a rise in sales of anti-depressant drugs in the Middle East, particularly in countries with high prevalence rates of diabetes. However, the extent of this impact may be limited by factors such as the availability and affordability of these drugs, as well as cultural attitudes towards mental health treatment. It's also worth noting that the link between diabetes and depression is complex, and addressing the root causes of both conditions may require a multifaceted approach that includes lifestyle interventions, psychological support, and medical treatment for both conditions. Overall, while the high prevalence of diabetes in the Middle East could potentially impact the anti-depressant drugs market, the relationship between these two factors is likely to be complex and multifactorial.

middle east anti-depressants drugs market

Market Dynamics

Market Growth Drivers

  1. Growing incidence of depression: Depression is a common mental health disorder in the Middle East, affecting a significant portion of the population. The increasing incidence of depression is driving the demand for antidepressant drugs.
  2. Increasing awareness of mental health: There is a growing awareness of mental health disorders in the Middle East, including depression. This is leading to increased diagnosis and treatment of depression, which is driving the demand for antidepressant drugs.
  3. Favorable government initiatives: Governments in the Middle East are increasingly focusing on mental health as a public health priority. They are implementing various initiatives to improve mental health services, including the availability of antidepressant drugs.
  4. Increasing healthcare expenditure: Healthcare expenditure is increasing in the Middle East, leading to improved access to healthcare services, including mental health services.

Market Restraints

  1. Stigma associated with mental health disorders: Mental health disorders are still stigmatized in the Middle East, which may discourage people from seeking treatment for depression.
  2. Limited availability of healthcare professionals: There is a shortage of healthcare professionals in the Middle East, particularly in the mental health sector. This can limit access to mental health services, including antidepressant drugs.
  3. High cost of antidepressant drugs: Antidepressant drugs can be expensive, which may limit access for some individuals in the Middle East.
  4. Lack of regulatory framework: The Middle East lacks a uniform regulatory framework for the approval and distribution of drugs, including antidepressant drugs. This can lead to delays in drug approvals and distribution, which can limit access to antidepressant drugs.

Competitive Landscape

Key Players

  • GlaxoSmithKline plc
  • AstraZeneca
  • Novartis AG
  • Endo Pharmaceuticals plc
  • Johnson & Johnson
  • Apotex Inc.
  • Bausch Health Companies Inc.
  • Lundbeck
  • Purdue Pharma
  • Takeda Pharmaceutical Company Limited
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Mylan N.V.
  • Novartis AG

Healthcare Policies and Regulatory Landscape

United Arab Emirates (UAE): The UAE Ministry of Health and Prevention regulates the registration and approval of drugs, including antidepressants. To be approved for sale, drugs must go through a rigorous process that includes clinical trials and review by the ministry. In the UAE, many antidepressants are available for purchase over the counter without a prescription. However, in order to obtain reimbursement for prescription antidepressants, patients must have health insurance that covers mental health conditions.

Saudi Arabia: The Saudi Food and Drug Authority regulates the registration and approval of drugs, including antidepressants. To be approved for sale, drugs must go through a rigorous process that includes clinical trials and review by the authority. In Saudi Arabia, reimbursement for prescription antidepressants is available through the government's healthcare program for Saudi nationals and residents.

Qatar: The Qatar Ministry of Public Health regulates the registration and approval of drugs, including antidepressants. To be approved for sale, drugs must go through a rigorous process that includes clinical trials and review by the ministry. In Qatar, reimbursement for prescription antidepressants is available through the government's healthcare program for Qatari nationals and residents.

Egypt: The Egyptian Drug Authority regulates the registration and approval of drugs, including antidepressants. To be approved for sale, drugs must go through a rigorous process that includes clinical trials and review by the authority. In Egypt, reimbursement for prescription antidepressants is available through the government's healthcare program for Egyptian citizens.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anti-Depressants Drugs Market Segmentation

Drug Class

The market is divided into monoamine oxidase inhibitors, atypical antidepressants, tricyclic, serotonin, and norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, and others based on pharmacological class. In 2021, the selective serotonin reuptake inhibitors (SSRIs) market segment held the biggest market share. The strength of the pipeline of top players to assess new potential candidates in this drug class, combined with the clinical advantage of SSRIs over conventional medications in the management and treatment of depression, is anticipated to accelerate the segment's growth.

  • Tricyclic Antidepressants (TCAs) - Amitriptyline (Elavil), Amoxapine (Asendin), Desipramine (Norpramin), Doxepin (Silenor), Imipramine (Tofranil), Nortriptyline (Pamelor), Protriptyline (Vivactil), Trimipramine (Surmontil)
  • Selective Serotonin Reuptake Inhibitors (SSRIs) - Citalopram (Cipramil), Dapoxetine (Priligy), Escitalopram (Cipralex), Fluoxetine (Prozac or Oxactin), Fluvoxamine (Faverin), Paroxetine (Seroxat), Sertraline (Lustral), Vortioxetine (Brintellix)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) - Desvenlafaxine (Pristiq), Duloxetine (Cymbalta), Levomilnacipran (Fetzima), Venlafaxine (Effexor XR)
  • Monoamine Oxidase Inhibitors (MAOIs) - Socarboxazid (Marplan), Phenelzine (Nardil), Selegiline (Emsam), Tranylcypromine (Parnate)
  • Serotonin Antagonist and Reuptake Inhibitors (SARI) - Etoperidone (Axiomin, Etonin), Lorpiprazole (Normarex), Mepiprazole (Psigodal), Nefazodone (Serzone, Nefadar), Trazodone (Desyrel)
  • Others

Indication

By Indication, the major depressive disorder segment was the major contributor in 2021 and is expected to maintain its lead during the forecast period, owing to an increase in the prevalence of major depressive disorder and initiatives taken by governments and private organizations about the development of drugs. However, the obsessive-compulsive disorder segment is expected to witness considerable growth during the forecast period, owing to an increase in the prevalence of mental disorders and an increase in the number of approval for anxiety drugs.

  • Major Depressive Disorder
  • Anxiety Disorders
  • Attention Deficit Hyperactivity Disorder
  • Others

Route of Administration

Based on the route of administration the market is segmented into:

  • Oral
  • Injectable
  • Others

End-Users

Based on end users the market is segmented into:

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

Hospital pharmacies, retail pharmacies, and online pharmacies are the three types of pharmacies that make up the market based on the distribution channel. In 2019, the hospital pharmacies segment dominated the world market. Nonetheless, the expansion of the retail pharmacy market might be attributed to patients' increasing demand for these establishments. Due to the growing prevalence of online pharmacies in emerging countries, the segment of online pharmacies is estimated to see a profitable CAGR over the forecast timeframe.

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 17 March 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up